Autoimmune hepatitis with normal IgG at diagnosis: Subtype without selective elevation of IgG but similar histological features and treatment response

2018 ◽  
Vol 56 (01) ◽  
pp. E2-E89
Author(s):  
J Hartl ◽  
G Wong ◽  
K Zachou ◽  
A Ashgar ◽  
S Pape ◽  
...  
2010 ◽  
Vol 45 (4) ◽  
pp. 457-467 ◽  
Author(s):  
Mårten Werner ◽  
Sven Wallerstedt ◽  
Stefan Lindgren ◽  
Sven Almer ◽  
Einar Björnsson ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Stefan Sorin Arama ◽  
Catalin Tiliscan ◽  
Cristina Negoita ◽  
Alexandru Croitoru ◽  
Victoria Arama ◽  
...  

Objective. This study compared the eradication rates of ofHelicobacter pylori(HP) infection by a 7-day and 14-day anti-HP regimen.Materials and Methods. An open, randomized, prospective study was performed to evaluate the response to anti-HP treatment in adult HP-positive patients following a 7-day course (Regimen A) of a proton pump inhibitor in association with clarithromycin and amoxicillin compared to a 14-day course (Regimen B). Gastric biopsies were performed at baseline and two months after anti-HP treatment.Results. Seventy-eight patients aged 18–64 years (28 males, 50 females) diagnosed with HP infection were included. Fifty-two (66.7%) patients received Regimen B and 26 (33.3%) Regimen A. The overall eradication rate was 70.5%. Better treatment response (p<0.01) was seen in Regimen B (44/52, 84.2% versus 11/26, 42.3%). Significant improvement in histological features was seen in regimen B. There has been significant overall reduction in endoscopic aspects of gastric and duodenal lesions in both regimens. Younger patients ≤35 years had a better response to Regimen B. Better treatment response was seen in women, urban residents, and those with tertiary level of education in both groups.Conclusion. 14-day anti-HP regimen offered a significant better overall eradication of HP in study population.


Hepatology ◽  
2010 ◽  
Vol 52 (6) ◽  
pp. 2247-2248 ◽  
Author(s):  
Christoph Schramm ◽  
Christina Weiler-Normann ◽  
Christiane Wiegard ◽  
Stefanie Hellweg ◽  
Susanne Müller ◽  
...  

2019 ◽  
Vol 5 (3) ◽  
pp. 256-264 ◽  
Author(s):  
Hala Agina ◽  
Nermine Ehsan ◽  
Taghreed Abd-Elaziz ◽  
Ghada Abd-Elfatah ◽  
Eman Said ◽  
...  

2019 ◽  
Vol 70 (1) ◽  
pp. e401
Author(s):  
Laura Patricia Llovet ◽  
Oswaldo Ortiz ◽  
Montserrat García-Retortillo ◽  
Raquel Vinuesa ◽  
Judith Gómez-Camarero ◽  
...  

2015 ◽  
Vol 33 (Suppl. 2) ◽  
pp. 53-64 ◽  
Author(s):  
Dina G. Tiniakos ◽  
John G. Brain ◽  
Yvonne A. Bury

The diagnosis of autoimmune hepatitis (AIH) is based on a combination of biochemical, immunological and histological features and exclusion of other causes of liver disease. Typical histological features include a chronic hepatitis pattern of injury with portal inflammation and interface activity, predominance of plasma cells in the portal infiltrate, emperipolesis, and hepatocellular rosette formation. Centrilobular injury with prominent hepatocellular necrosis and mononuclear inflammation is now recognised in the histological spectrum of AIH and may represent an early stage of the disease. Liver histology plays a major role in clinical diagnostic scoring systems and is important to confirm or support the clinical diagnosis of AIH. This review focuses on the role of histopathology in AIH and highlights the contribution of histological interpretation to the diagnosis of AIH, differential diagnosis from other entities, recognition of concurrent liver disease, and identification of the so-called overlap or variant syndromes, and addresses the importance of liver biopsy in the management and prognosis of patients with AIH.


Sign in / Sign up

Export Citation Format

Share Document